These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15589603)

  • 21. c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment.
    Raspollini MR; Amunni G; Villanucci A; Pinzani P; Simi L; Paglierani M; Taddei GL
    Clin Cancer Res; 2004 May; 10(10):3500-3. PubMed ID: 15161707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
    Krug LM; Crapanzano JP; Azzoli CG; Miller VA; Rizvi N; Gomez J; Kris MG; Pizzo B; Tyson L; Dunne M; Heelan RT
    Cancer; 2005 May; 103(10):2128-31. PubMed ID: 15812822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
    Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
    J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis.
    Tayal S; Classen E; Bemis L; Robinson WA
    Anticancer Res; 2005; 25(3B):2215-20. PubMed ID: 16158966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of KIT (CD117) expression in gallbladder carcinomas by tissue microarray.
    Langner C; Lemmerer M; Kornprat P
    Eur J Surg Oncol; 2004 Oct; 30(8):847-50. PubMed ID: 15336730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
    Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of KIT expression in small cell lung cancer.
    López-Martin A; Ballestín C; Garcia-Carbonero R; Castaño A; Lopez-Ríos F; López-Encuentra A; Sánchez-Cespedes M; Castellano D; Bartolomé A; Cortés-Funes H; Paz-Ares L
    Lung Cancer; 2007 Jun; 56(3):405-13. PubMed ID: 17420067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
    Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
    Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
    Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
    Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
    Ikeda K; Tate G; Suzuki T; Mitsuya T
    Gynecol Oncol; 2005 May; 97(2):323-9. PubMed ID: 15863125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
    Hotte SJ; Winquist EW; Lamont E; MacKenzie M; Vokes E; Chen EX; Brown S; Pond GR; Murgo A; Siu LL
    J Clin Oncol; 2005 Jan; 23(3):585-90. PubMed ID: 15659505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of c-kit (CD117) in neuroendocrine tumours--a target for therapy?
    Kostoula V; Khan K; Savage K; Stubbs M; Quaglia A; Dhillon AP; Hochhauser D; Caplin ME
    Oncol Rep; 2005 Apr; 13(4):643-7. PubMed ID: 15756436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer.
    Tanaka S; Tanaka H; Yamamoto T; Shuto T; Takemura S; Hai S; Sakabe K; Uenishi T; Hirohashi K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):228-34. PubMed ID: 16708300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
    Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
    Tanimoto H; Shigemasa K; Sasaki M; Katayama H; Kusumi I; Parmley TH; O'Brien TJ; Ohama K
    Oncol Rep; 2000; 7(6):1209-12. PubMed ID: 11032915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
    Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
    Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.